Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2026.07.007 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Jin Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenet…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Immune System Diseases. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Children's Hospital of Philadelphia, National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVES: Paediatric-onset immune-mediated inflammatory diseases (IMIDs), including juvenile idiopathic arthritis and related rheumatic diseases, remain genetically undercharacterised. We aimed to define shared and category-specific genetic architecture across paediatric IMIDs, compare signals with adult IMIDs, and identify therapeutic opportunities. METHODS: We analysed 24 paediatric IMIDs classified as autoimmune, polygenic-autoinflammatory, mixed-pattern, or allergic. Genome-wide association analyses included 18,086 cases and 131,019 controls of European ancestry. We estimated single nucleotide polymorphism (SNP)-based heritability, genetic correlations, and polygenic overlap; performed subset-based meta-analysis; and conducted functional annotation, gene prioritisation, pathway and protein network analyses, adult-IMID comparison, and drug-target prioritisation. RESULTS: SNP-based heritability ranged from 28.9% for allergic IMIDs to 61.9% for autoimmune IMIDs. Genetic correlation and polygenic modelling supported partial sharing across categories with category-specific components. Meta-analysis identified 39 genome-wide significant loci outside the Major Histocompatibility Complex (MHC) region, including 15 previously unreported loci; 19 loci were shared between categories. Gene-prioritisation and protein interaction analyses identified a core MHC-centred antigen-presentation network, with category-enriched modules involving complement, innate/barrier pathways, epithelial biology, and type 2 immunity. Enriched pathways included nuclear factor κB signalling, T helper 17 related pathways, Janus kinase-signal transducer and activator of transcription signalling, programmed cell death protein 1/programmed death‑ligand 1, cytotoxic T‑lymphocyte associated protein 4 regulation, and osteoclast differentiation, several of which are relevant to rheumatic diseases. Paediatric IMIDs shared broad polygenic architecture with adult IMIDs, whereas top-ranked genes converged strongly with adult rheumatic diseases. Priority Index analysis identified 178 high-scoring genes, including 43 approved or investigational IMID drug targets. CONCLUSIONS: Paediatric-onset IMIDs share core pathways with adult forms but exhibit distinct genetic architecture shaped by age-specific immune and neurodevelopmental biology. These findings provide a genomic framework for paediatric precision medicine, guiding classification, risk prediction, and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cell Biology, Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, State Key Laboratory of Experimental Hematology, Tianjin Key Labo…
- Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School…
- Department of Radiation Oncology and Department of Cancer Genetics and Epigenetics, City of Hope, Duarte, CA, USA.
- Department of Pathology, Cytogenetics Laboratory, City of Hope National Medical Center, Irwindale, CA, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Förderung
- Children's Hospital of Philadelphia
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Qu, H. Q., March, M. E., Glessner, J. T., Fu, Y., Chen, J., Xu, Y., Chen, H., Li, Y. R., Xia, Q., Mentch, F. D., Youssefian, L., Vahidnezhad, H., Saeidian, A. H., Chang, X., Liu, W., Wei, W., & Hakonarson, H. (2026). Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.07.007
Vancouver
Li J, Qu HQ, March ME, Glessner JT, Fu Y, Chen J, et al. Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.07.007
BibTeX
@article{Li2026,
author = {Li, Jin and Qu, Hui-Qi and March, Michael E and Glessner, Joseph T and Fu, Yuqiao and Chen, Jiayue and Xu, Yang and Chen, Hao and Li, Yun R and Xia, Qianghua and Mentch, Frank D and Youssefian, Leila and Vahidnezhad, Hassan and Saeidian, Amir H and Chang, Xiao and Liu, Wei and Wei, Wei and Hakonarson, Hakon},
title = {Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2026.07.007}
}
EUVIMED